These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 19122255)

  • 1. Cardiac resynchronization therapy in hemodynamically unstable heart failure patients.
    Rao BH; Kalavakolanu S; Chandrasekar K; Sastry BK; Narasimhan C
    Indian Heart J; 2007; 59(2):185-7. PubMed ID: 19122255
    [No Abstract]   [Full Text] [Related]  

  • 2. [Intra-aortic balloon pumping in treating acute heart failure].
    Bisenkov LN; Skorik VI
    Vestn Khir Im I I Grek; 1981 Nov; 127(11):132-7. PubMed ID: 7036508
    [No Abstract]   [Full Text] [Related]  

  • 3. Current concepts in the use of intra-aortic balloon counterpulsation.
    Underwood MJ; Firmin RK; Graham TR
    Br J Hosp Med; 1993 Oct 6-19; 50(7):391-7. PubMed ID: 8261284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulatory assist devices in heart failure patients.
    Hiestand BC
    Heart Fail Clin; 2009 Jan; 5(1):55-62, vi. PubMed ID: 19026386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of the hemodynamically unstable patient.
    Lee FA
    Cardiol Clin; 1988 Feb; 6(1):63-79. PubMed ID: 3048675
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intraaortic balloon pump insertion through the subclavian artery. Subclavian artery insertion of IABP.
    Marcu CB; Donohue TJ; Ferneini A; Ghantous AE
    Heart Lung Circ; 2006 Apr; 15(2):148-50. PubMed ID: 16574539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Congestive heart failure.
    Sidd JJ
    Orthop Clin North Am; 1978 Jul; 9(3):745-60. PubMed ID: 692995
    [No Abstract]   [Full Text] [Related]  

  • 8. Short-term hemodynamic effects of cardiac resynchronization therapy in patients with heart failure, a narrow QRS duration, and no dyssynchrony.
    Williams LK; Ellery S; Patel K; Leyva F; Bleasdale RA; Phan TT; Stegemann B; Paul V; Steendijk P; Frenneaux M
    Circulation; 2009 Oct; 120(17):1687-94. PubMed ID: 19822812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Percutaneous intra-aortic balloon: use in Iowa.
    Phillips SJ; Brown TM; Gordon DF; Iannone L; Kongtahworn C; Beshany SE; Zeff RH
    J Iowa Med Soc; 1980 Dec; 70(12):503-6. PubMed ID: 7441029
    [No Abstract]   [Full Text] [Related]  

  • 10. Optimized cardiac resynchronization therapy in patients with congestive heart failure.
    Niu HX; Hua W; Zhang S; Sun X; Chen KP; Wang FZ; Chen X
    Chin Med J (Engl); 2007 Apr; 120(7):605-7. PubMed ID: 17442212
    [No Abstract]   [Full Text] [Related]  

  • 11. Acute haemodynamic effects of intra-aortic balloon pump and cardiac resynchronization therapy.
    Bonanno C; Ometto R; La Vecchia L; Fontanelli A
    J Cardiovasc Med (Hagerstown); 2008 Jul; 9(7):719-24. PubMed ID: 18545074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hemodynamic effects of an implanted abdominal aortic counterpulsation device designed for chronic use in graded heart failure.
    Nanas JN; Mason JW; Yoshiyuki T; Chiang BY; Olsen DB
    Life Support Syst; 1985; 3 Suppl 1():245-9. PubMed ID: 3870572
    [No Abstract]   [Full Text] [Related]  

  • 13. Extracorporeal membrane oxygenation for treatment of cardiac failure in adult patients.
    Luo XJ; Wang W; Hu SS; Sun HS; Gao HW; Long C; Song YH; Xu JP
    Interact Cardiovasc Thorac Surg; 2009 Aug; 9(2):296-300. PubMed ID: 19351687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anaphylactic shock: the advantages of intra aortic balloon counter pulsation for the treatment of heart failure.
    Yeguiayan JM; Ravisy J; Lenfant F; Pillet M; Freysz M
    Resuscitation; 2007 Mar; 72(3):493-5. PubMed ID: 17141395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Shock].
    Okada M
    Ryoikibetsu Shokogun Shirizu; 1996; (12):67-77. PubMed ID: 9047411
    [No Abstract]   [Full Text] [Related]  

  • 16. eComment: Re: Extracorporeal membrane oxygenation for treatment of cardiac failure in adult patients.
    Bockeria LA; Shatalov KV; Arnautova IV; Makhalin MM
    Interact Cardiovasc Thorac Surg; 2009 Aug; 9(2):300. PubMed ID: 19628544
    [No Abstract]   [Full Text] [Related]  

  • 17. Acute pulmonary oedema during cardiac resynchronization therapy device implantation: management with the activation of intra-aortic balloon pump.
    Altin T; Candemir B; Ozkaramanli D; Akyurek O; Karaoguz R; Guldal M
    Europace; 2008 Oct; 10(10):1232-4. PubMed ID: 18559332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fulminant myocarditis survivor after 56 hours of non-responsive cardiac arrest successfully returned to normal life by cardiac resynchronization therapy: a case report.
    Sugamura K; Sugiyama S; Kawano H; Horio E; Ono S; Kojima S; Kaikita K; Sagishima K; Sakamoto T; Yoshimura M; Kinoshita Y; Ogawa H
    J Cardiol; 2006 Dec; 48(6):345-52. PubMed ID: 17243629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deflation Timing Influences Intra-Aortic Balloon Pump-Mediated Carotid Blood Flow Reversal: A Case Report.
    Schutt RC; Bhimiraj A; Estep JD; Guha A; Trachtenberg BH; Garami Z
    Circ Heart Fail; 2016 Sep; 9(9):. PubMed ID: 27582283
    [No Abstract]   [Full Text] [Related]  

  • 20. A mechanistic investigation into how long-term resynchronization therapy confers ongoing cardiac functional benefits and improved exercise capacity.
    Schlosshan D; Barker D; Lewis N; Pepper C; Tan LB
    Am J Cardiol; 2009 Mar; 103(5):701-8. PubMed ID: 19231337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.